Bio-Sourcing is developing a new generation of biotherapeutics, in particular monoclonal antibodies for global unmet medical needs : available, affordable, sustainable.
About
Bio-Sourcing changes the design paradigm of these new biotherapeutics thanks to the mastery of several breakthrough technologies including genome editing (CRISPR).
The Bio-Sourcing disruptive approach leads to a drastic reduction in capital requirements and production costs, especially for large volumes, as well as an improvement in the quality/efficiency of biopharmaceuticals through better glycosylation.
The technological approach developed by BioSourcing has already given rise to biotherapeutics approved by the health industry and regulatory bodies (FDA, EMA).
Bio-Sourcing strongly contributes to sustainable development, in particular in drastically reducing the carbon footprint.
Bio-Sourcing is a fully operational biotechnology company, based in Liège, Belgium. Its team is made up of the best scientists, international experts in their field and has developed strategic partnerships with leaders in the pharmaceutical and biotechnology industry.
The Bio-Sourcing disruptive approach leads to a drastic reduction in capital requirements and production costs, especially for large volumes, as well as an improvement in the quality/efficiency of biopharmaceuticals through better glycosylation.
The technological approach developed by BioSourcing has already given rise to biotherapeutics approved by the health industry and regulatory bodies (FDA, EMA).
Bio-Sourcing strongly contributes to sustainable development, in particular in drastically reducing the carbon footprint.
Bio-Sourcing is a fully operational biotechnology company, based in Liège, Belgium. Its team is made up of the best scientists, international experts in their field and has developed strategic partnerships with leaders in the pharmaceutical and biotechnology industry.
